LTGO

Latigo Biotherapeutics, Inc.

Healthcare · Biotechnology

13.10$ +1.4% vs. previous close Closing price · As of: Nov 13, 2026

Statements

Income Statement

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement LTGO
Line item	2024	2025
Revenue	0.00	0.00
Research & Development	0.94	1.65
Selling, General & Administrative	0.11	0.18
Total Operating Expenses	1.05	1.84
Operating Income	-1.05	-1.84
Pre-Tax Income	-1.02	-1.81
Net Income	-1.02	-1.81
EBITDA	-1.05	-1.83

Data as of: November 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.